Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
Neurobehavioral burden of multiple sclerosis with nanotheranostics.
Efficacy and safety of laquinimod in multiple sclerosis: current status.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical features.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Association between neuromyelitis optica and tuberculosis in a Chinese population.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
Mode of action and clinical studies with alemtuzumab.
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
MOG-IgG in neuromyelitis optica.
Simvastatin in patients with progressive multiple sclerosis.
Differential microRNA expression in blood in multiple sclerosis.
Prevalence and Impact of Pain in Adults Aging With a Physical Disability: Comparison to a US General Population Sample.
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
[Multiple sclerosis.]
Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Improving the quality of mental health care in Multiple Sclerosis.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.

Pages